Maccura Biotechnology Co.Ltd

300463

CNE1000020H3

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-06-27 EDT			5-day change	1st Jan Change
11.38 ^CNY	-0.70%		-3.15%	-24.49%

06-27	Maccura Biotechnology Co.Ltd Announces Final Profit Distribution Plan on A Shares for the Year 2023, Payable on July 3, 2024	CI
06-21	Maccura Biotechnology Gets Nod to Register Automatic Biochemical Analyzer	MT

Maccura Biotechnology Co.Ltd Approves Cash Dividend for 2023

June 04, 2024 at 03:34 pm

The Maccura Biotechnology Co.Ltd held its Annual General Meeting on 03 June 2024, and approved 2023 profit distribution plan, Cash dividend/10 shares (tax included): CNY 1.55000000.

Latest news about Maccura Biotechnology Co.Ltd

Maccura Biotechnology Co.Ltd Announces Final Profit Distribution Plan on A Shares for the Year 2023, Payable on July 3, 2024	06-27	CI
Maccura Biotechnology Gets Nod to Register Automatic Biochemical Analyzer	06-21	MT
Maccura Biotechnology Co.Ltd Approves Cash Dividend for 2023	06-04	CI
Maccura Biotechnology Co.Ltd Proposes Final Cash Dividend for the Year 2023	04-24	CI
Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	04-24	CI
Maccura Biotechnology Co.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Tranche Update on Maccura Biotechnology Co.Ltd's Equity Buyback Plan announced on February 6, 2024.	04-01	CI
Maccura Biotechnology Co.Ltd announces an Equity Buyback for CNY 100 million worth of its shares.	02-05	CI
Maccura Biotechnology Co.Ltd authorizes a Buyback Plan.	02-04	CI
Maccura Biotechnology Co.Ltd(SZSE:300463) dropped from Shenzhen Stock Exchange Component A Share Index	12-11	CI
Maccura Biotechnology Co.Ltd(SZSE:300463) dropped from Shenzhen Stock Exchange Component Index	12-11	CI
Maccura Biotechnology Co.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Maccura Biotechnology Registers Infectious Disease Diagnosis Kit	23-08-04	MT
Maccura Biotechnology Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-28	CI
Maccura Biotechnology Co.Ltd Approves Cash Dividend for 2022, Payable on May 29, 2023	23-05-16	CI
Maccura Biotechnology Co.Ltd Proposes Final Cash Dividend for 2022	23-04-25	CI
Maccura Biotechnology Co.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI
Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-24	CI
Maccura Biotechnology Co.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-24	CI
Maccura Biotechnology Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-15	CI
Mega Genomics Braves Market Turbulence, Raises $19.5 Million in Hong Kong IPO	22-06-20	MT
Mega Genomics Braves Market Turbulence with Launch of $34 Million Hong Kong IPO	22-06-10	MT
DMaccura Biotechnology Co.Ltd Approves Cash Dividend for 2021, Payable on May 19, 2022	22-05-13	CI
Maccura Biotechnology Co.Ltd Approves Cash Dividend for 2021	22-05-11	CI
Maccura Biotechnology Co.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI

Chart Maccura Biotechnology Co.Ltd

Duration

Period

More charts

Maccura Biotechnology Co., Ltd., formerly Sichuan Maccura Biotechnology Co., Ltd., is a China-based company principally engaged in research, development, manufacture and sales of in-vitro diagnostics products and the sales of in-vitro diagnostic products of foreign brands as an agent. The Company provides hundreds of products which cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-31 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Maccura Biotechnology Co.Ltd

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

11.38 CNY

Average target price

15.46 CNY

Spread / Average Target

+35.85%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
MACCURA BIOTECHNOLOGY CO.LTD	-24.49%	950M
BIOMÉRIEUX	-11.78%	11.24B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-13.76%	7.29B
LANTHEUS HOLDINGS, INC.	+29.50%	5.57B
AUTOBIO DIAGNOSTICS CO., LTD.	-19.19%	3.68B
ANDON HEALTH CO., LTD.	+7.62%	2.58B
10X GENOMICS, INC.	-65.24%	2.33B
VITROLIFE AB	-10.48%	2.23B
MYRIAD GENETICS, INC.	+27.80%	2.21B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-19.12%	1.57B

Diagnostic & Testing Substances